A treatment must show superiority over a placebo to be considered effective.
Common methods used to evaluate drug therapy:
Utilization of randomized control trials (RCTs) to compare drug effectiveness against a placebo.
A placebo is defined as a substance that holds no pharmacological value but controls the belief that the medication will have an effect on the individual.
Evidence Supporting Effectiveness
Recent studies affirming drug therapy:
Soomro et al. (2008)
Reviewed 17 studies focused on the use of SSRIs (Selective Serotonin Reuptake Inhibitors) in patients with Obsessive-Compulsive Disorder (OCD) which often accompanies depression.
Findings indicated that SSRIs significantly outperformed placebos in reducing OCD symptoms within a three-month post-treatment period, indicating short-term effectiveness.
Kahn et al. (1986)
Conducted a study of 250 patients over an 8-week duration.
Results emphasized that benzodiazepines (BZs) were considerably superior to placebos in managing symptoms.
Limitations regarding effectiveness evaluation:
Most studies evaluating drug therapy have a short duration, typically only 3 to 4 months, implying a lack of long-term effectiveness data (Koran, 2007).
Side Effects of Drug Therapy
Common side effects associated with SSRIs and other antidepressants:
Nausea
Headaches
Insomnia
For Tricyclic antidepressants, potential side effects include:
Hallucinations
Irregular heartbeat
While SSRIs are effective, the side effects might lead patients to forgo medication adherence.
Criticism of Drug Therapy
Symptomatic treatment vs. underlying causes:
Drug therapy is often critiqued for alleviating symptoms without addressing root psychological issues.
Example: Adult depression stemming from childhood trauma may see temporary relief through medication, yet the underlying trauma remains unaddressed, which can lead to the 'revolving door syndrome'—a scenario where patients repeatedly return for treatment without significant improvement.
Comparison with Other Treatment Modalities
Economic and practicality perspective:
Drug therapy is considered more cost-effective compared to psychotherapies and talking therapies.
Drug prescriptions on the NHS allow for easier access to treatment.
Practitioners require less time per patient, typically only needing monthly or bi-monthly consultations to monitor progress and medication effects.
Evaluation of Ethical Issues in Drug Therapy
Ethical concerns in drug regimen evaluation
Use of Placebos:
Fundamental ethical issue in research: Patients should not be assigned inferior treatments when effective alternatives are available.
Substituting a placebo in place of an effective treatment violates this ethical obligation and exposes individuals to potentially ineffective therapies.
Patient Information and Consent:
Issues regarding informed consent arise, as many patients may struggle to comprehend all the critical information related to the prescribed medication and its possible side effects.
Valid consent is often compromised when patients are either unable to follow the details or when doctors fail to fully disclose vital information, such as the slim probabilities of pharmacological benefits or might present an exaggerated view of drug efficacy.
The nature of drug therapy tends to seek quick solutions, potentially overlooking alternative therapies that might require more commitment and resources yet enable deeper healing.
Neurotransmitters and Their Relation to Drug Therapy
Relevant neurotransmitters associated with various psychological conditions:
Dopamine: Linked primarily with schizophrenia.
Serotonin: Often correlated with conditions such as depression.